International Journal of Scientific and Research Publications

IJSRP, Volume 4, Issue 12, December 2014 Edition [ISSN 2250-3153]


Prostate Adenocarcinoma: are EGFR-targeted drugs of therapeutic relevance for castrate-resistant patients?
      I. Sadaoui, V. Barrès, H. Amrani Hassani Joutei , N. El Gnaoui , W. Mahfoud, H. Benomar and S. Nadifi
Abstract: The progression of normal prostatic epithelium to androgen-dependent cancer and, eventually, castrate-resistant prostate cancer is a complex process involving many different growth regulatory signals. Activation of epidermal growth factor receptor (EGFR) has been implicated in prostate cancer cell growth.

Reference this Research Paper (copy & paste below code):

I. Sadaoui, V. Barrès, H. Amrani Hassani Joutei , N. El Gnaoui , W. Mahfoud, H. Benomar and S. Nadifi (2018); Prostate Adenocarcinoma: are EGFR-targeted drugs of therapeutic relevance for castrate-resistant patients?; Int J Sci Res Publ 4(12) (ISSN: 2250-3153). http://www.ijsrp.org/research-paper-1214.php?rp=P363524
©️ Copyright 2011-2022 IJSRP - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.